These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 905972

  • 1. Inactivation of bovine and human thrombin and factor Xa by antithrombin III studied with amidolytic methods.
    Odegård OR, Abildgaard U, Lie M, Miller-Andersson M.
    Thromb Res; 1977 Aug; 11(2):205-61. PubMed ID: 905972
    [No Abstract] [Full Text] [Related]

  • 2. Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.
    Teien AN, Abildgaard U, Höök M, Lindahl U.
    Thromb Res; 1977 Aug; 11(2):107-17. PubMed ID: 905965
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanism of inactivation of trypsin by antithrombin.
    Danielsson A, Björk I.
    Biochem J; 1982 Oct 01; 207(1):21-8. PubMed ID: 6817749
    [Abstract] [Full Text] [Related]

  • 5. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH.
    Am J Clin Pathol; 1978 Apr 01; 69(4):299-359. PubMed ID: 347919
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sulfated galactan is a catalyst of antithrombin-mediated inactivation of alpha-thrombin.
    Melo FR, Pereira MS, Monteiro RQ, Foguel D, Mourão PA.
    Biochim Biophys Acta; 2008 Sep 01; 1780(9):1047-53. PubMed ID: 18558097
    [Abstract] [Full Text] [Related]

  • 9. Characterization of human, bovine, and horse antithrombin III.
    Kurachi K, Schmer G, Hermodson MA, Teller DC, Davie EW.
    Biochemistry; 1976 Jan 27; 15(2):368-73. PubMed ID: 1247522
    [Abstract] [Full Text] [Related]

  • 10. A differential effect of low-affinity heparin on the inhibition of thrombin and factor Xa by antithrombin.
    Nordenman B, Nordling K, Björk I.
    Thromb Res; 1976 Jan 27; 17(3-4):595-600. PubMed ID: 7368180
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V, Lee AY, Clardy J, Tulinsky A.
    Protein Sci; 1996 May 27; 5(5):825-35. PubMed ID: 8732754
    [Abstract] [Full Text] [Related]

  • 12. Formation of prethrombin-E, thrombin, and thrombin-E and their inhibition with antithrombin and enzyme inhibitors.
    Seegers WH, Andary TJ.
    Thromb Res; 1974 Jun 27; 4(6):869-74. PubMed ID: 4858456
    [No Abstract] [Full Text] [Related]

  • 13. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
    Callas DD, Fareed J.
    Thromb Res; 1995 Jun 01; 78(5):457-60. PubMed ID: 7544924
    [No Abstract] [Full Text] [Related]

  • 14. Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome.
    Kolev K, Léránt I, Skopál J, Kelemen A, Nagy Z, Machovich R.
    Thromb Haemost; 2005 Jul 01; 94(1):82-7. PubMed ID: 16113788
    [Abstract] [Full Text] [Related]

  • 15. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
    Hijikata A, Okamoto S, Kikumoto R, Tamao Y.
    Thromb Haemost; 1979 Oct 31; 42(3):1039-45. PubMed ID: 159513
    [Abstract] [Full Text] [Related]

  • 16. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM, Nawroth PP, Kisiel W, Handley D, Drillings M, Bartos J.
    J Clin Invest; 1984 Dec 31; 74(6):1910-21. PubMed ID: 6439737
    [Abstract] [Full Text] [Related]

  • 17. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V, Béguin S, Boneu B, Hemker HC.
    Thromb Haemost; 1997 Feb 31; 77(2):312-6. PubMed ID: 9157588
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms for the anticoagulant effects of synthetic antithrombins.
    Ofosu FA.
    Adv Exp Med Biol; 1993 Feb 31; 340():213-26. PubMed ID: 8154338
    [Abstract] [Full Text] [Related]

  • 19. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR, Lie M, Abildgaard U.
    Haemostasis; 1976 Feb 31; 5(5):265-75. PubMed ID: 1017722
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
    Odegård OR, Lie M.
    Thromb Res; 1978 Apr 31; 12(4):697-700. PubMed ID: 663903
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.